SOURCES SOUGHT
Q -- NEW - Base + 4 Option Year- Oncotype DX
- Notice Date
- 8/1/2022 11:25:16 AM
- Notice Type
- Sources Sought
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- 257-NETWORK CONTRACT OFFICE 17 (36C257) ARLINGTON TX 76006 USA
- ZIP Code
- 76006
- Solicitation Number
- 36C25723Q0003
- Response Due
- 8/1/2022 8:00:00 AM
- Archive Date
- 08/31/2022
- Point of Contact
- Ognian Ivanov, Contract Specialist, Phone: 210-694-6302
- E-Mail Address
-
ognian.ivanov@va.gov
(ognian.ivanov@va.gov)
- Awardee
- null
- Description
- Sources Sought Notice This Sources Sought Notice is for informational and planning purposes only and shall not be construed as a solicitation or as an obligation or commitment by the Government. This notice is intended strictly for Market Research. This is a Request for Information ONLY. This is NOT a solicitation for proposals, bids, proposal abstracts, or quotations. The Government is conducting a market survey to help determine the availability and technical capability of qualified service-disabled veteran-owned small businesses, veteran-owned small businesses, small businesses, HUBZone small businesses and/or other large businesses capable of serving the needs identified below. This notice of intent is for open market as well as Federal Supply Schedule items. GENERAL The purpose of the resulting contract will be to provide a Blanket Purchase Agreement (BPA) for Laboratory Fee Basis Testing for Oncotype DX Genomic Oncology Testing for the Central Texas Veterans Health Care System (CTVHCS), at 1901 Veterans Memorial Blvd, Temple, Texas 76504. Contractor is to provide healthcare resources in accordance with Public Law 104.262 and 38 U.S.C. 8153. BACKGROUND Oncotype DX genomic oncology assays are clinically validated genomic tests that can provide both a prediction of current chemotherapy advantage as well as an individualized prediction of a patient s ten-year risk of cancer recurrence. This provides personalized information for tailoring treatment based on the biology of an individual s disease. CTVHCS has been using Genomic Health reference laboratory for the analysis and score reporting of breast, colon and prostate oncotype diagnosis for 4 years. SCOPE OF WORK Contractor shall provide in accordance with the specifications outlined Oncotype DX genomic oncology testing, during the period of 6/5/2023 through 6/4/2024 with four (4) one-year option renewals extending from 6/5/2024 through 6/4/2028. Services shall include: The performance, reporting and score of Oncotype DX analytical testing for Breast, Colon, Breast DCIS, Pan-Cancer Tissue Test, and Prostate cancers. SPECIMEN TESTING The Contractor and/or subcontractor shall provide the full range of clinical and anatomic pathology diagnostic testing capabilities to execute all required tests as annotated in the Scope of Work. Contractor shall make available the following test information: Requisition form requirements Alphabetized test name list Test order code Specimen collection and preservation requirements Test method employed (indicate if testing performed in duplicate) and interpretations Test reference intervals adjusted for age, sex or race, when required Test specific sensitivity, specificity and interferences, when required Result code Test critical values, if any Policy for critical value notification CPT coding Test turnaround times (minimum and maximum times indicated); where the turnaround time is defined as the time between pick-up of specimen by the Contractor and receipt of results by a government facility. Schedule of test performance (specific days of week indicated) Location of test performance by test name (i.e. name of primary laboratory, name of separate branch/division of primary lab, name and address of secondary (sub-contracted) laboratory must be cited) Contractor shall notify the Contracting Officer and each Government facility of any test information modifications no later than two weeks prior to the implementation date of the test change. All reference laboratory testing shall be executed in accordance with standard industry practices. It is preferred that test methods are FDA approved. Any non-FDA approved method being performed shall have a disclaimer and documented validation plan. Upon request, the validation plan and validation results shall be made available to the COR or designee. The Contractor shall ensure the accurate and timely performance of laboratory testing services on the biomedical materials. SPECIMEN RETENTION All anatomic pathology materials (e.g., histology blocks, slides or other diagnostic material) generated by the VA shall be returned within 7 days after final diagnosis is reported. RESULTS REPORTING The results of testing shall be reported within the prescribed turnaround times provided by the Contractor as part of the test information. A report of laboratory testing results must be issued either as a printed final copy- faxed and mailed, or through the host-to-host electronic transmission of the test results. In circumstances where electronic delivery is not possible, the Contractor shall deliver the reports without an additional charge by expedited overnight courier shipping, mailing and/or transportation services by hand within 24 hours, or by telephone facsimile to a protected machine identified to the Contractor by the VA. Delivery by electronic mail i.e. MS Outlook, etc. is prohibited. Each test report shall, at minimum, include the following information: Patient's full name Patient s identification number, e.g. social security number (SSN) Physician s name (if supplied) Government laboratory accession number (if supplied) Submitting facility name Submitting facility account number Patient's location (clinic/ward) (if supplied) Test(s) ordered Date/time of specimen collection (when available) Date/time test completed Test result Reference intervals (adjusted for age, sex or race, when appropriate) Toxic and therapeutic ranges, if applicable Flagged abnormal results Reference laboratory accession number Name and address of testing laboratory Any other information the laboratory has that may indicate a questionable validity of test results. Specimen inadequacy shall be reported with documentation supporting its unsuitability for testing. Test results determined by the contractor to be critical, shall be communicated by telephone to a designated Government contact person(s) at the originating Government laboratory facility upon verification of the critical test result. The telephonic report shall be followed by an electronic transmission. CUSTOMER SERVICE Contractor shall provide customer service that is accessible by toll-free telephone service 24 hours per day, 7 days per week to assist Government staff for tracking and resolving related issues/problems that may arise in the performance under this contract. Upon award, the Contractor shall provide the name(s) and telephone number(s) of contractor employees who will address the following customer services throughout the contract performance period: Telephone Inquiries Telephone inquiries are divided into four major categories with additional subcategories defining the type of inquiry and the Government s minimum time expectation for meeting this service. Specimen Collection Routine inquiries, questions and clarifications regarding collection requirements shall be addressed at the time of the initial call. Esoteric inquiries, questions and clarifications regarding collection requirements that require further research shall be addressed within ½ hour of the initial call. Testing Inquiries regarding the status of pending orders shall be addressed at the time of the initial call. Esoteric inquiries when information is requested regarding methodology, correlation, interferences, reflex tests, etc. shall be addressed within two hours of the initial call. Technical Expertise Test utilization inquiries where information is required as to the most appropriate test to be ordered shall be addressed within two business hours of initial call. Result interpretation inquiries shall be addressed within four business hours of initial call. Consultative services where information is required regarding the clinical significance of tests shall be addressed within twenty-four business hours of the initial call. Account follow-up Information general in nature yet specific to the account, e.g. test pricing, equipment repair, supply ordering, etc. shall be addressed within four hours of the initial call. The Contractor shall notify the originating laboratory by telephone of specimens cancelled due to unacceptability for reasons relating to volume, specimen container, identification, loss of specimen, etc. The Government will place orders for specimen collection and transportation supplies by telephone or through written or electronic methods. Monthly billing and test report summaries shall begin on the first day of the month and include the last day of the month. F. VA-FSC shall require the following information in compliance with the Prompt Pay Act and Business Requirements. Taxpayer ID number (TIN) Remit Address information The VA Purchase Order (PO) number Contact information: (Personal name, Email, and Phone) VA Point of contact information (Personal name, Email, and Phone) The Period of Performance dates (POP Beginning and Ending) All discount information if applicable (Percent and Date Terms) Reagents used with pricing per unit No freight charges to be added to the invoice CTVHCS shall not be responsible for payment of services and or supplies which were not requested Accordance with the contract. H. CTVHCS will NOT pay for tests that are not clearly identified by product number on the invoice. I. Invoices are to be separate for Amarillo and Lubbock laboratories but the usage of the same PO number is acceptable for billing purposes. J. Invoices will be electronically submitted to the Tungsten website at: K. http://ww.tungsten-network.com/uk/en/ L. Tungsten direct vendor support number is 877-489-6135 for VA contracts. M. All invoices submitted through Tungsten to VA-FSC should mirror the current submission of invoice. CONSULTATIVE SERVICES / UTILIZATION REPORTS Contractor shall prove consultative services that are consistent with the services offered to other contracted customers without compensation. These services may include consultations by laboratory professionals or experienced physicians on test or methodology selection or test result interpretation. The purpose of this notice is to gain knowledge of potential qualified sources and their size classification/socioeconomic status (service-disabled veteran owned small business, veteran owned small business, women-owned small business, HUB Zone, 8(a), small business or large business, relative to NAICS 621511. Responses to this notice will be used by the Government to make appropriate acquisition decisions. A solicitation is not currently available. If a solicitation is issued, it will be announced on Commercial Business Opportunities website http://www.beta.sam.gov or GSA E-Buy at a later date, and all interested parties must respond to that solicitation announcement separately from the responses to this announcement. Please advise if you can provide the service/supplies for this requirement. Please submit all information to Ognian Ivanov mailto:ognian.ivanov@va.gov no later than Wednesday ,August 31, 2022, 11:00 AM ET (10:00 AM CT).
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/ac578f2d2a6c4925ad704178450c3f0d/view)
- Place of Performance
- Address: Olin E. Teague Veterans' Medical Center 1901 Veterans Memorial Drive, Temple, TX 76504-7176, USA
- Zip Code: 76504-7176
- Country: USA
- Zip Code: 76504-7176
- Record
- SN06409854-F 20220803/220801230135 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |